Ibrutinib alone and in combination with dexamethasone and carfilzomib significantly inhibits cell proliferation in primary mediastinal B-cell lymphoma (PMBL): Ibrutinib may be a future targeted agent in combination therapy in patients with PMBL Meeting Abstract
| Authors: | Lee, S.; Yin, C.; Ayello, J.; Morris, E.; Harrison, L.; van de Ven, C.; Barth, M. J.; Miles, R. R.; Galardy, P. J.; Goldman, S.; Lim, M. S.; Hermiston, M. L.; McAllister-Lucas, L.; Giulino-Roth, L.; Perkins, S. L.; Cairo, M. S. |
| Abstract Title: | Ibrutinib alone and in combination with dexamethasone and carfilzomib significantly inhibits cell proliferation in primary mediastinal B-cell lymphoma (PMBL): Ibrutinib may be a future targeted agent in combination therapy in patients with PMBL |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021803155 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.4852.4852 |
| Notes: | Meeting Abstract: 4852 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
